ctrl K

Price Alert

Sino Biopharmaceutical Li... (SBMFF)

OTC: SBMFF · Real-Time Price · USD

0.99

0.00 (0.10%)

At close: Aug 13, 2025, 12:40 PM

0.99

0.00%

After-hours: Aug 13, 2025, 08:00 PM EDT

Sino Biopharmaceutical Balance Sheet Statement

Financials in CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	9.57B	9.45B	8.65B	9.6B
Short-Term Investments	5.03B	1.55B	8.27B	6.19B
Long-Term Investments	26.34B	25.18B	16.96B	18.97B
Other Long-Term Assets	1.04B	3.78B	9.5B	7.5B
Receivables	4.97B	4.6B	4.64B	4.29B
Inventory	2.37B	1.99B	2.33B	1.94B
Other Current Assets	295.61M	2.52B	1.58B	1.25B
Total Current Assets	24.69B	23.81B	25.93B	23.5B
Property-Plant & Equipment	10.29B	9.91B	9.25B	8.52B
Goodwill & Intangibles	3.06B	928.94M	1.91B	1.71B
Total Long-Term Assets	40.72B	39.8B	38.13B	37.04B
Total Assets	65.41B	63.6B	64.06B	60.54B
Account Payables	1.5B	1.33B	1.88B	1.79B
Deferred Revenue	n/a	n/a	n/a	n/a
Short-Term Debt	7.68B	11.14B	9.8B	6.66B
Other Current Liabilities	7.61B	3.35B	2.11B	1.68B
Total Current Liabilities	19.56B	22.61B	20.15B	15.35B
Long-Term Debt	2B	1.07B	3.93B	5.21B
Other Long-Term Liabilities	997.36M	1.46B	1.71B	1.94B
Total Long-Term Liabilities	3.08B	2.83B	5.97B	7.47B
Total Liabilities	22.63B	25.43B	26.12B	22.81B
Total Debt	9.78B	12.58B	13.98B	12.12B
Common Stock	414.38M	414.62M	414.9M	415.44M
Retained Earnings	n/a	29.34B	23.07B	23.07B
Comprehensive Income	n/a	n/a	-10.08B	-9.23B
Shareholders Equity	31.96B	30.47B	29.75B	30.29B
Total Investments	31.36B	25.82B	25.23B	25.17B